These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17208328)

  • 1. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
    Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
    Grieu F; Li WQ; Iacopetta B
    Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
    Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
    Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
    Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
    Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
    Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
    Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.